tiprankstipranks
Xilio Therapeutics Inc (XLO)
NASDAQ:XLO
US Market
XLO
Xilio Therapeutics
RESEARCH TOOLSreports

Xilio Therapeutics (XLO) Financial Statements

Compare
219 Followers

Xilio Therapeutics Financial Overview

Xilio Therapeutics's market cap is currently $48.11M. The company's EPS TTM is $0.81; its P/E ratio is -21.38; Xilio Therapeutics is scheduled to report earnings on March 23, 2026, and the estimated EPS forecast is $-0.66. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 43.77M$ 6.34M$ 0.00$ 0.00$ 0.00
Gross Profit$ 42.23M$ 6.34M$ 0.00$ 0.00$ -1.50M
Operating Income$ -41.98M$ -60.58M$ -79.13M$ -89.15M$ -75.04M
EBITDA$ -40.44M$ -58.00M$ -77.23M$ -87.30M$ -73.70M
Net Income$ -35.04M$ -58.24M$ -76.40M$ -88.22M$ -75.80M
Balance Sheet
Cash & Short-Term Investments$ 137.53M$ 55.29M$ 44.70M$ 120.39M$ 198.05M
Total Assets$ 154.69M$ 71.08M$ 60.93M$ 139.16M$ 221.60M
Total Debt$ 6.95M$ 8.14M$ 11.46M$ 19.94M$ 20.74M
Net Debt$ -130.58M$ -47.15M$ -33.25M$ -100.45M$ -177.32M
Total Liabilities$ 119.41M$ 53.48M$ 24.10M$ 33.52M$ 36.17M
Stockholders' Equity$ 35.27M$ 17.60M$ 36.83M$ 105.65M$ 185.43M
Cash Flow
Free Cash Flow$ -5.51M$ -18.41M$ -69.11M$ -77.59M$ -81.85M
Operating Cash Flow$ -4.99M$ -18.38M$ -68.62M$ -75.72M$ -80.75M
Investing Cash Flow$ -518.00K$ -36.00K$ -486.00K$ -1.87M$ -1.10M
Financing Cash Flow$ 87.78M$ 29.20M$ -6.55M$ -69.00K$ 260.67M
Currency in USD

Xilio Therapeutics Earnings and Revenue History

Income Statement >

Xilio Therapeutics Debt to Assets

Balance Sheet >

Xilio Therapeutics Cash Flow

Cash Flow >

Xilio Therapeutics Forecast EPS vs Actual EPS

Earnings >